DCPD
Based on 1 Customer Validation
DCPD is an amine substance with both embryotoxicity and teratogenicity, and its total effect ED50 is 0.6 μmol per egg. DCPD induces early and late embryonic death, and causes multiple embryonic malformations including microcephaly, hypoplastic optic cup, eyelid and corneal defects. DCPD can serve as a calcium phosphate additive for biomimetic α-tricalcium phosphate bone cement, which inhibits the transformation of α-tricalcium phosphate into calcium-deficient hydroxyapatite, blocks the release of Gelatins (HY-Y1365), and effectively prolongs the setting time of bone cement. DCPD is applicable to studies related to embryonic malformations.\n
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 95.0%
- CAS 番号: 4175-38-6
- 分子式: C18H28N2
- 分子量:272.43
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
-
溶剤 & 溶解度
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
DCPD prolongs the initial and final setting times of gelatin-α-TCP bone cement, and 15 wt.% DCPD completely inhibits setting; it reduces the long-term conversion rate of α-TCP to CDHA in gelatin-α-TCP bone cement and prevents the release of gelatin from gelatin-α-TCP bone cement during immersion in physiological solution[2].
DCPD dissolves rapidly in gelatin-α-TCP bone cements immersed in physiological solutions, and the dissolution rate decreases with the increase of initial DCPD content[2].
DCPD improves the mechanical properties of gelatin-α-TCP bone cement; it alters the morphological development during the curing process of gelatin-α-TCP bone cement, forming a denser surface and smaller crystals at DCPD concentrations of 2.5 wt.% and 5 wt.%[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:White Leghorn (3-day/72-76 h embryos)[1]
-
Dosage:0.36 μmol per egg; 0.73 μmol per egg; 1.5 μmol per egg; 2.9 μmol per egg
-
Administration:local injection onto inner shell membrane over embryo; single dose
-
Result:Triggered 3% early deaths, 3% late malformed deaths, 23% malformed survivors and 30% affected embryos at 0.36 μmol per egg.
Triggered 3% early deaths, 57% malformed survivors and 60% affected embryos at 0.73 μmol per egg.
Triggered 83% malformed survivors and 83% affected embryos at 1.5 μmol per egg.
Triggered 10% early deaths, 3% late malformed deaths, 43% malformed survivors and 57% affected embryos at 2.9 μmol per egg.
Exhibited an overall ED50 (deaths plus malformations) of 0.6 μmol per egg.
Induced prevalent small head malformations (96%) plus minor ocular, body wall, skeletal, wing and oedema lesions among 51 malformed embryos with 70 recorded defects.
化学情報
-
CAS 番号 4175-38-6
-
性状 Solid
-
分子量 272.43
-
分子式 C18H28N2
-
Color Brown to reddish brown
-
SMILES
C1(NC2CCCCC2)=CC=C(NC3CCCCC3)C=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
溶剤 & 溶解度
DMSO : 20 mg/mL (73.41 mM; Need ultrasonic and warming; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (271 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Korhonen A, et al. Embryotoxicity of sixteen industrial amines to the chicken embryo. Journal of Applied Toxicology. 1983;3(2):112-117. [Content Brief]
[2]. Panzavolta S, et al. Optimization of a biomimetic bone cement: Role of DCPD. Journal of Inorganic Biochemistry. 2011;105(8):1060-1065. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.6707 mL | 18.3533 mL | 36.7067 mL | 91.7667 mL |
| 5 mM | 0.7341 mL | 3.6707 mL | 7.3413 mL | 18.3533 mL | |
| 10 mM | 0.3671 mL | 1.8353 mL | 3.6707 mL | 9.1767 mL | |
| 15 mM | 0.2447 mL | 1.2236 mL | 2.4471 mL | 6.1178 mL | |
| 20 mM | 0.1835 mL | 0.9177 mL | 1.8353 mL | 4.5883 mL | |
| 25 mM | 0.1468 mL | 0.7341 mL | 1.4683 mL | 3.6707 mL | |
| 30 mM | 0.1224 mL | 0.6118 mL | 1.2236 mL | 3.0589 mL | |
| 40 mM | 0.0918 mL | 0.4588 mL | 0.9177 mL | 2.2942 mL | |
| 50 mM | 0.0734 mL | 0.3671 mL | 0.7341 mL | 1.8353 mL | |
| 60 mM | 0.0612 mL | 0.3059 mL | 0.6118 mL | 1.5294 mL |
DCPD 関連分類
HY-171985 関連分類
Powered by Bioz